| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 03/31/2004 | EP1402015A2 A soluble complex comprising a retroviral surface glycoprotein |
| 03/31/2004 | EP1402014A1 A process for purification of recombinant porphobilinogen deaminase |
| 03/31/2004 | EP1402012A2 Methods of using 18903 to treat pain and pain-related disorders |
| 03/31/2004 | EP1402009A1 Novel mixed lineage kinase (7) (mlk7) polypeptide, polynucleotides encoding the same, and methods of use thereof |
| 03/31/2004 | EP1402008A2 Method for purifying an enzyme, a purified enzyme produced thereby, and use of this enzyme |
| 03/31/2004 | EP1402001A2 Anti-microbial peptides and compositions |
| 03/31/2004 | EP1402000A2 Structural and cytoskeleton-associated proteins |
| 03/31/2004 | EP1401999A2 B7 related protein-2 molecules and uses thereof |
| 03/31/2004 | EP1401918A2 Biodegradable poly(beta-amino esters) and uses thereof |
| 03/31/2004 | EP1401871A1 Immunological binding molecules inhibiting the syncytial fusion of trophoblast cells |
| 03/31/2004 | EP1401869A1 Molecules and methods for inhibiting shedding of kim-1 |
| 03/31/2004 | EP1401868A2 Ion channel modulators |
| 03/31/2004 | EP1401867A2 Mycobacterial antigens expressed under low oxygen tension |
| 03/31/2004 | EP1401864A1 Methods and compositions for modulating ace-2 activity |
| 03/31/2004 | EP1401863A1 Somatostatin-dopamine chimeric analogs |
| 03/31/2004 | EP1401862A2 Peptide compounds for counteracting reactive oxygen species and free radicals |
| 03/31/2004 | EP1401859A2 Chimeric flavivirus vectors |
| 03/31/2004 | EP1401858A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 03/31/2004 | EP1401857A2 Purification of human serum albumin |
| 03/31/2004 | EP1401855A2 Novel fibroblast growth factor and nucleic acids encoding same |
| 03/31/2004 | EP1401853A1 Modulators of pharmacological agents |
| 03/31/2004 | EP1401849A1 Plant artificial chromosomes, uses thereof and methods of preparing plant artificial chromosomes |
| 03/31/2004 | EP1401833A2 Chemical derivatives and the use thereof as an anti-elomerase agent |
| 03/31/2004 | EP1401808A2 Gpe analogs and peptidomimetics |
| 03/31/2004 | EP1401504A1 Uv-screening peptide-flavonoid conjugates |
| 03/31/2004 | EP1401502A1 Pharmaceutical formulation |
| 03/31/2004 | EP1401495A2 T cell induced tissue repair and regeneration |
| 03/31/2004 | EP1401494A1 Tumor therapy |
| 03/31/2004 | EP1401491A1 Methods for inducing an immune response with an elevated th1/th2 ratio, by intracellular induction of nfkappab |
| 03/31/2004 | EP1401490A1 Tsg101 as inhibitor of hiv production |
| 03/31/2004 | EP1401486A2 Novel human proteins, polynucleotides encoding them and methods of using the same |
| 03/31/2004 | EP1401485A1 A pharmaceutical combination comprising either (s)-2-ethoxy-3 4-(2- 4-methane sulfonyl oxyphenyl ethoxy)phenyl] propanoic acid or 3- 4- 2- (4-tert-butoxy carbonylamino phenyl) ethoxy] phenyl -(s)-2-ethoxy propanoic acid and insulin |
| 03/31/2004 | EP1401484A1 Combination therapies using vitamin b12 and interferon for treatment of viral, proliferative and inflammatory diseases |
| 03/31/2004 | EP1401483A1 Combination therapies using vitamin b12 and therapeutic agents for treatment of viral, proliferative and inflammatory diseases |
| 03/31/2004 | EP1401482A1 Yin yang-1 |
| 03/31/2004 | EP1401481A1 Mucosal repair by tff dimer peptides |
| 03/31/2004 | EP1401480A2 Use of endostatin in the treatment of ocular neovascularization |
| 03/31/2004 | EP1401478A2 Antimicrobial peptides |
| 03/31/2004 | EP1401476A2 Igf antagonist peptides |
| 03/31/2004 | EP1401475A2 Prmts as modifiers of the p53 pathway and methods of use |
| 03/31/2004 | EP1401474A2 Methods for inducing sustained immune response |
| 03/31/2004 | EP1401473A2 Transporters comprising spaced arginine moieties |
| 03/31/2004 | EP1401472A2 Alternative splice forms of proteins as basis for multiple therapeutic modalities |
| 03/31/2004 | EP1401471A2 Composition and method for treating cells |
| 03/31/2004 | EP1401470A2 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use |
| 03/31/2004 | EP1401469A2 Therapeutic use and identification of modulators of a hedgehog signalling pathway or one of its target pathways |
| 03/31/2004 | EP1401468A2 Induction of blood vessel formation through administration of polynucleotides encoding sphingosine kinases |
| 03/31/2004 | EP1401467A1 Alpha-fetoprotein peptides and uses thereof |
| 03/31/2004 | EP1401456A1 Method fron determining the efficacy of reverse cholesterol transport enhancing agents |
| 03/31/2004 | EP1401443A1 Novel anti-infectives |
| 03/31/2004 | EP1401431A2 Human growth hormone antagonists |
| 03/31/2004 | EP1401429A2 Use of potent, selective and non toxic c-kit inhibitors for treating mastocytosis |
| 03/31/2004 | EP1401426A1 Ptpase inhibitors and method of using same |
| 03/31/2004 | EP1401418A2 Topical treatments using alkanolamines |
| 03/31/2004 | EP1401410A2 Immunomodulation and effect on cell processes relating to serotonin family receptors |
| 03/31/2004 | EP1401394A1 Immunopotentiator for mammary gland of dairy cows containing lactoferrin as an active ingredient |
| 03/31/2004 | EP1401377A2 Methods for treating cancer |
| 03/31/2004 | EP1401376A2 Colloidal metal compositions and methods |
| 03/31/2004 | EP1401375A2 Methods for inhibiting macrophage colony stimulating factor and c-fms-dependent cell signaling |
| 03/31/2004 | EP1401293A1 Calorically dense liquid oral supplement |
| 03/31/2004 | EP1401286A1 Method of inhibiting fungal growth |
| 03/31/2004 | EP1401281A2 Toll/interleukin-1 receptor adaptor protein (tirap) |
| 03/31/2004 | EP1401276A2 Implantation of biological pacemaker that is molecularly determined |
| 03/31/2004 | EP1401269A2 Transgenic animal model of bone mass modulation |
| 03/31/2004 | EP1401268A1 Treatment or replacement therapy using transgenic stem cells delivered to the gut |
| 03/31/2004 | EP1401259A2 Delta-4 desaturase genes and uses thereof |
| 03/31/2004 | EP1366059A4 Methods and compositions for modulating gluconeogenesis using pgc-1 |
| 03/31/2004 | EP1294742B1 Urokinase inhibitors |
| 03/31/2004 | EP1232174A4 Compositions and methods for counteracting effects of reactive oxygen species and free radicals |
| 03/31/2004 | EP1220685B1 Pharmaceutical compositions of fibrinolytic agent |
| 03/31/2004 | EP1218026B1 Preparation of a medicament to enhance healing of the sternum after sternotomy |
| 03/31/2004 | EP1210102A4 Tgf-alpha polypeptides, functional fragments and methods of use therefor |
| 03/31/2004 | EP1181318B1 Monoclonal antibodies, synthetic and biotechnological derivatives thereof acting as ngf-antagonist molecules |
| 03/31/2004 | EP1140139B9 Use of erythropoietin or erythropoietin derivatives for the treatment of cerebral ischaemia |
| 03/31/2004 | EP1109526B1 Improved stability for injection solutions |
| 03/31/2004 | EP1053020B1 Absorbable microparticles |
| 03/31/2004 | EP1049484B1 Use of il-11 to enhance cell mediated immunity for treating various viral and parasitic infections and cancer |
| 03/31/2004 | EP1019507B1 Amino-terminally truncated rantes as chemokine antagonists |
| 03/31/2004 | EP1012256B1 Recombinant fusion proteins based on ribosome-inactivating proteins of european mistletoe viscum album |
| 03/31/2004 | EP1011710A4 Methods and compositions for optimization of oxygen transport by cell-free systems |
| 03/31/2004 | EP0980253B1 Somatostatin and somatostatin agonists for treating insulin insensitivity and syndrome x |
| 03/31/2004 | EP0977578B1 Compositions to enhance the cytoprotective effects of polycyclic phenolic compounds through the synergistic interaction with anti-oxidants |
| 03/31/2004 | EP0973887B1 Porcine leptin protein, nucleic acid sequences coding therefor and uses thereof |
| 03/31/2004 | EP0935652B1 Keratinocyte growth factor-2 products |
| 03/31/2004 | EP0877624B1 Streptococcal c5a peptidase vaccine |
| 03/31/2004 | EP0866860B1 Novel tyrosine kinase receptors and ligands |
| 03/31/2004 | EP0858343B1 Continuous low-dose cytokine infusion therapy |
| 03/31/2004 | EP0858323B1 Process to manufacture implants containing leuprolide |
| 03/31/2004 | EP0784677B1 Inhibitor of stem cell proliferation and uses thereof |
| 03/31/2004 | EP0742833B1 Recombinant baculovirus and use thereof in the production of monoclonal antibodies |
| 03/31/2004 | EP0735818B1 MACROPHAGE INFLAMMATORY PROTEINS MIP-3, MIP-4 AND MIP-1gamma |
| 03/31/2004 | EP0681477B1 Genetic modification of neural stem cells |
| 03/31/2004 | CN1486368A Methods for the production of multimeric proteins, and related compositions |
| 03/31/2004 | CN1486327A 载脂蛋白类似物 Apolipoprotein analogues |
| 03/31/2004 | CN1486204A Compositions for inducing islet neogenesis, containing gastrin/CCK receptor ligands and egf receptor ligands |
| 03/31/2004 | CN1486199A A device and a method for dispensing at least two mutually reactive components |
| 03/31/2004 | CN1486192A Binding domain-immunoglobulin fusion proteins |
| 03/31/2004 | CN1486191A Combination therapy using receptor tyrosine kinase inhibitors and angiogenesis inhibitors |
| 03/31/2004 | CN1486184A Lactam compound to inhibit beta-amyloid peptide release or synthesis |
| 03/31/2004 | CN1486179A Pharmaceutical or cosmetic composition and use of a pkc inhibitor with an mmp inhibitor for inhibiting langerhans' cell migration |